Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary

被引:0
作者
Dóra Török
Gudrun Eckhardt
János Sólyom
机构
[1] Semmelweis University,2nd Department of Paediatrics, Faculty of Medicine
来源
European Journal of Pediatrics | 2003年 / 162卷
关键词
Blood-spot 17-hydroxyprogesterone; Congenital adrenal hyperplasia; 21-Hydroxylase deficiency;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to assess the effectivity of the identification of patients with congenital adrenal hyperplasia (CAH) in Hungary in the absence of systematic neonatal screening and to estimate the incidence. Dried blood-spot samples of patients clinically suspected at any age to have CAH were collected between 1978 and 1998 throughout the whole country. 17-Hydroxyprogesterone (17-OHP) was measured by radioimmunoassay. Age-specific cut-offs were used. The effectivity of the system was retrospectively assessed. Additional cases were sought to assess the overall incidence of CAH in Hungary. Among the 1,837 patients investigated, 185 cases of CAH were identified. The overall effectivity was 94.7%. The sensitivity and the specificity were 98.9% and 94.2%, respectively. Salt-wasting (SW) boys were, on average, diagnosed 2 weeks later than SW girls, while both boys and girls with the simple virilising (SV) form were diagnosed at similar ages (2 versus 2.5 years). An additional 19 cases were diagnosed during the study period using other methods (plasma and urinary steroid profiles without blood-spot 17-OHP measurements). The incidence of classical CAH in Hungary was 1:14,300 (CI 95% between 1:12,450 and 1:16,795). Presuming that the incidence of CAH is the same among boys and girls, one can calculate that the diagnosis was missed in 24 boys (2 SW, 22 SV). Conclusion: it is possible to identify the vast majority of classical cases of congenital adrenal hyperplasia without a neonatal mass screening programme. However, a significant number of boys with the simple virilising form missed whereas both salt-wasting boys and girls are diagnosed safely.
引用
收藏
页码:844 / 849
页数:5
相关论文
共 50 条
  • [41] Prenatal Dexamethasone for Congenital Adrenal Hyperplasia
    Dreger, Alice
    Feder, Ellen K.
    Tamar-Mattis, Anne
    JOURNAL OF BIOETHICAL INQUIRY, 2012, 9 (03) : 277 - 294
  • [42] Fertility in patients with congenital adrenal hyperplasia
    Claahsen-van der Grinten, H. L.
    Stikkelbroeck, N. M. M. L.
    Sweep, C. G. J.
    Hermus, A. R. M. M.
    Otten, B. J.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (05) : 677 - 685
  • [43] OSTEOCALCIN IN CONGENITAL ADRENAL-HYPERPLASIA
    LISA, L
    NERADILOVA, M
    TOMASOVA, N
    SOUTOROVA, M
    ZIMAK, J
    BONE, 1995, 16 (01) : 57 - 59
  • [44] Congenital adrenal hyperplasia: A lifelong disorder
    Hughes, Ieuan A.
    HORMONE RESEARCH, 2007, 68 : 84 - 89
  • [45] Congenital adrenal hyperplasia: Phenotype and genotype
    Hughes, I
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2002, 15 : 1329 - 1340
  • [46] Giant Macroorchidism in Congenital Adrenal Hyperplasia
    Zadik, Z.
    Burundukov, E.
    Zung, A.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2009, 22 (12) : 1095 - 1097
  • [47] Pseudohypoaldosteronism Masquerading as Congenital Adrenal Hyperplasia
    C. G. Delhikumar
    Parameswaran Narayanan
    S. Mahadevan
    The Indian Journal of Pediatrics, 2012, 79 : 115 - 116
  • [48] Congenital adrenal hyperplasia: transitional care
    Hughes, IA
    GROWTH HORMONE & IGF RESEARCH, 2004, 14 : S60 - S66
  • [49] Congenital adrenal hyperplasia with cholestatic jaundice
    Ali, Nisreen Feroz
    Zafar, Farhana
    Bangash, Areeb Sohail
    Malik, Abdul
    Mohammedi, Karimunnisa
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2014, 64 (01) : 110 - 114
  • [50] Congenital adrenal hyperplasia: Adolescence and transition
    Conway, Gerard S.
    HORMONE RESEARCH, 2007, 68 : 155 - 157